MOLyF : Bone Marrow and Follicular Lymphoma
ConditionLymphoma, Follicular
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorRennes University Hospital
About this trial
This is a prospective single-center study designed to assess potential differences in cell composition between bone marrows of patients with follicular lymphoma and those from control subjects.
Follicular lymphoma is the most common indolent lymphoma. It is characterised by systematic relapses and bone marrow dissemination in 70% of patients at the time of diagnosis.
Although relapses are thought to be related to refractory tumour cells nested in a supportive microenvironment in the bone marrow, the mechanisms involved are poorly understood.
To study the specificities of the bone marrow of patients with follicular lymphoma, It is necessary to compare them with control samples.
This study takes advantage of surgeries involving sternotomies to recover lost bone marrow and establish a bone marrow bank of patients without hematological disease.
This bank will be used to set up control cohorts for other clinical trials involving patients with follicular lymphoma.
Eligibility criteria
Qualifiers
Major patient
Patient hospitalized in the thoracic, cardiac and vascular surgery department for surgery involving a sternotomy
Patient with free, informed, written consent
Patient covered by a health insurance scheme
Disqualifiers
History of haematological malignancy or haemogram disturbance
Immunomodulating treatment: immunosuppressants, corticoids, antineoplastics
Persons covered by articles L. 1121-5 to L. 1121-8 and L. 1122-1-2 of the French Public Health Code (e.g. minors, protected adults, etc.)].
Trial design
Treatments tested in this trial
- Sampling
Treatment groups
200 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov